| Name | Title | Contact Details |
|---|
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals. vBloc Therapy is now approved by the Food and Drug Administration for weight loss in adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels.* *Individuals should have first tried to lose weight by diet and exercise in a supervised program within the last 5 years before receiving the Maestro System.
MD Buyline is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National Blood Ctr/S Florida Region is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At CoorsTek Medical, our vision is to make lives measurably better. We are the partner of choice for medical innovators and medical-device providers worldwide whose success requires access to leading-edge medical device development experts and the related set of specialized product development and manufacturing capabilities.
Creganna is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.